Related Experiment Video
Updated: May 12, 2026

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
Published on: May 1, 2018
Phage survival: the biodegradability of M13 phage display library in vitro
L'ubomíra Tóthová1, Janka Bábíčková, Peter Celec
1Institute of Molecular Biomedicine, Comenius University, Bratislava, Slovakia. tothova.lubomira@gmail.com
Abstract:
Administration of bacteriophages is used for phage therapy modulation of gut microbiome or for in vivo phage display. The aim of the study was to analyze the survival of M13 phage in different body fluids and tissues in vitro. The survival of M13 phage was measured in vitro in human blood, saliva, urine, artificial gastric juice (AGJ), and mouse homogenates of stomach, jejunum, and colon after defined time points (5, 15, or 45 Min). The plates were inspected after overnight incubation and the plaques were counted. No phage was recovered after 5 Min of incubation with AGJ. In urine, the phage survival was decreased by 44% after 5 Min of incubation (P = 0.004). In saliva, the recovered titer was decreased by 33% and 88% (P < 0.05) after 15 and 45 Min, respectively. Phage coincubation with jejunum homogenate led to significant decrease of phage titer by 72% (P < 0.01) after 15 Min and by 99% (P < 0.001) after 45 Min. Decreased survival of M13 phage depending on time of incubation was proved under several in vitro conditions, with low pH in the AGJ having the most detrimental effect on phage survival. Phage pharmacokinetics described in vitro might have applications for the use of bacteriophages in vivo.
Insights
Bacteriophage M13 survival was tested in human body fluids and mouse tissues. Low pH conditions, like in artificial gastric juice, severely impacted phage viability, suggesting implications for in vivo phage therapy applications.
Area of Science:
- Microbiology
- Biotechnology
Background:
- Bacteriophages are utilized in phage therapy for gut microbiome modulation and in vivo phage display.
- Understanding phage survival in physiological environments is crucial for therapeutic efficacy.
Purpose of the Study:
- To evaluate the in vitro survival rates of M13 phage in various human body fluids and mouse tissues.
- To determine the impact of different physiological conditions on phage viability over time.
Main Methods:
- M13 phage survival was assessed in human blood, saliva, urine, artificial gastric juice (AGJ), and mouse stomach, jejunum, and colon homogenates.
- Phage viability was measured at 5, 15, and 45-minute intervals post-incubation.
- Plaque assays were performed after overnight incubation to quantify phage recovery.
Main Results:
- No M13 phage recovery was observed after 5 minutes in AGJ.
- Significant phage survival reduction occurred in urine (44% at 5 min), saliva (33% at 15 min, 88% at 45 min), and jejunum homogenate (72% at 15 min, 99% at 45 min).
- Low pH in AGJ demonstrated the most detrimental effect on phage survival.
Conclusions:
- M13 phage survival is time-dependent and significantly reduced in certain in vitro physiological conditions.
- The findings highlight the challenges for phage stability in vivo and inform potential phage therapy strategies.
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle
Microbial Bioremediation of Plastics
Lysogenic Cycle of Bacteriophages

